Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study

Cancer Investigation

Volumn 27, Issue 4, 2009, Pages 430-434

  Yao, Jorge L ^a,b   Ryan, Charlotte K ^a   Francis, Charles W ^b   Kohli, Manlsh ^b   Taubman, Mark B ^b   Khorana, Alok A ^b  

^a Pathology   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Prostate cancer; Tissue factor; VEGF

Indexed keywords

POLYCLONAL ANTIBODY; THROMBOPLASTIN; TISSUE FACTOR ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PURIFICATION; TISSUE MICROARRAY; TUMOR VASCULARIZATION; CARCINOMA; CHEMISTRY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROSTATE TUMOR; VASCULARIZATION;

CARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; THROMBOPLASTIN; TISSUE ARRAY ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 65249133570     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802527247     Document Type: Article

References (33)

1. Nelen, V. Epidemiology of prostate cancer. Recent Results Cancer Res 2007, 175, 1-8.
2. Stewart, R.J.; Panigrahy, D.; Flynn, E.; Folkman, J. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. J Urol 2001, 165, 688-693.
3. Lissbrant, I.F.; Lissbrant, E.; Damber, J.E.; Bergh, A. Bloodvessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer. Scand J Urol Nephrol 2001, 35,437-452.
4. Carmeliet, P. Biomedicine. Clotting factors build blood vessels. Science 2001, 293, 1602-1604.
5. Zhang, Y; Deng, Y; Luther, T; Muller, M.; Ziegier, R.; Waldherr, R.; Stern, DM.; Nawroth, P.P. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994, 94, 1320-1327.
6. Rickles, F.R.; Patierno, S.; Fernandez, P.M. Tissue factor, thrombin, and cancer. Chest 2003, 124, 58S-68S.
7. Nakasaki, T; Wada, H.; Shigemori, C; Miki, C; Gabazza, E.C.; Nobori.T.; Nakamura, S.; Shiku, H. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 2002, 69, 247-254.
8. Ohta, S.; Wada, H.; Nakazaki, T; Maeda, Y; Nobori, T.; Shiku, H.; Nakamura, S.; Nagakawa, O.; Furuya, Y; Fuse, H. Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer. Anticancer Res 2002, 22,2991-2996.
9. Poon, R.T.; Lau, CP.; Ho, J.W.; Yu, W.C.; Fan, ST.; Wong, J. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res 2003, 9, 5339-5345.
10. Lopez-Pedrera, C; Barbarroja, N.; Dorado, G.; Siendones, E.; Velasco, F. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies. Leukemia 2006, 20, 1331-1340.
11. Akashi, T.; Furuya, Y; Ohta, S.; Fuse, H. Tissue factor expression and prognosis in patients with metastatic prostate cancer. Urology 2003, 62, 1078-1082.
12. Khorana, A.A.; Ahrendt, S.A.; Ryan, C.K.; Francis, C.W.; Hruban, R.H.; Hu, Y.C.; Hostetter, G.; Harvey, J.; Taubman, M.B. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 2007, 13, 2870-2875.
13. Bao, B.Y; Yao, J.; Lee, YF. 1 alpha, 25-dihydroxyvitamin d3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis 2006, 27,1883-1893.
14. Huang, J.; Yao, J.L.; Zhang, L.; Bourne, P.A.; Quinn, A.M.; di Sant'Agnese, P.A.; Reeder, J.E. Differential expression of interleukin-8 and its receptors in the neuroendocrine and non- neuroendocrine compartments of prostate cancer. Am J Pathol 2005, 166,1807-1815.
15. Rush, D.S.; Tan, J.; Baergen, R.N.; Soslow, R.A. H-caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 2001, 25, 253-258.
16. Browder, T.; Folkman, J.; Pirie-Shepherd, S. The hemostatic system as a regulator of angiogenesis. J Biol Chem 2000,275,1521- 1524.
17. Yu, J.L; May, L; Klement, P.; Weitz, J.I.; Rak, J. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy. SeminThromb Hemost 2004, 30, 21-30.
18. George, J.; Gondi, C.S.; Dinh, D.H.; Gujrati, M.; Rao, J.S. Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis. Clin Cancer Res 2007, 13, 3507-3517.
19. Guo, H.; Lin, Y; Zhang, H.; Liu, J.; Zhang, N.; Li, Y; Tang, Q.; Kong, D.; Ma, D. Tissue factor pathway inhibitor-2 was repressed by cpg hypermethylation through inhibition of klf6 binding in highly invasive breast cancer cells. BMC Mol Biol 2007, 8,110.
20. Sierko, E.; Wojtukiewicz, M.Z.; Kisiel, W. The role of tissue factor pathway inhibitor-2 in cancer biology. Semin Thromb Hemost 2007, 33, 653-659.
21. Wong, CM.; Ng, Y.L.; Lee, J.M.; Wong, C.C.; Cheung, O.F.; Chan, C.Y.; Tung, E.K.; Ching, Y.P.; Ng, I.O. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 2007, 45,1129-1138.
22. Abdulkadir, S.A.; Carvalhal, G.F.; Kaleem, Z.; Kisiel, W.; Humphrey, P.A.; Catalona, W.J.; Milbrandt, J. Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 2000, 31, 443-447.
23. Kaushal, V.; Mukunyadzi, P.; Siegel, E.R.; Dennis, R.A.; Johnson, D.E.; Kohli, M. Expression of tissue factor in prostate cancer correlates with malignant phenotype. Appl Immunohistochem Mol Mor- phol 2008, 16,1-6.
24. Delves, G.H.; Stewart, A.B.; Cooper, A.J.; Lwaleed, B.A. Prosta- somes, angiogenesis, and tissue factor. Semin Thromb Hemost 2007, 33, 75-79.
25. Ruf, W. Redundant signaling of tissue factor and thrombin incancer progression? J Thromb Haemost 2007, 5,1584-1587.
26. Hjortoe, G.M.; Petersen, L.C; Albrektsen, T; Sorensen, B.B.; Norby, P.L.; Mandal, S.K.; Pendurthi, U.R.; Rao, L.V. Tissue factorfactor Vila-specific up-regulation of il-8 expression in mda-mb-231 cells is mediated by par-2 and results in increased cell migration. Blood 2004, 103, 3029-3037.
27. Staton, C.A.; Chetwood, A.S.; Cameron, I.C.; Cross, S.S.; Brown, N.J.; Reed, M.W. The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut 2007, 56, 1426-1432.
28. Abraham, E.; Reinhart, K.; Opal, S.; Demeyer, I.; Doig, C; Rodriguez, A.L.; Beale, R.; Svoboda, P.; Laterre, P.F.; Simon, S.; Light, B.; Spapen, H.; Stone, J.; Seibert, A.; Peckelsen, C; De Deyne, C; Postier, R.; Pettila, V.; Artigas, A.; Percell, S.R.; Shu, V.; Zwingel- stein, C; Tobias, J.; Poole, L.; Stolzenbach, J.C.; Creasey, A.A. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003, 290, 238-247.
29. Laterre, PR; Wittebole, X.; Collienne, C. Pharmacological inhibition of tissue factor. Semin Thromb Hemost 2006, 32, 71-76.
30. Ohsawa, M.; Koyama, T.; Yamamoto, K.; Hirosawa, S.; Kamei, S.; Kamiyama, R. 1alpha,25-dihydroxyvitamin d(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized Idl. Circulation 2000, 102, 2867-2872.
31. Tenno, T; Oberg, F.; Mackman, N.; Nilsson, K.; Siegbahn, A. Pml/raralpha plays a role for basal activity and retinoid- induced repression of the tissue factor promoter in acute promyelocytic leukemia cells. Thromb Haemost 2003, 90, 930- 939.
32. Ma, Q.; Tobu, M.; Schultz, C; Jeske, W.; Hoppensteadt, D.; Walenga, J.; Cornelli, U.; Lee, J.; Linhardt, R.; Hanin, I.; Fareed, J. Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides. Thromb Res 2007, 119, 653-661.
33. Hembrough, T.A.; Swartz, G.M.; Papathanassiu, A.; Vlasuk, G.P.; Rote, W.E.; Green, S.J.; Pribluda, V.S. Tissue factor/factor Vila inhibitors block angiogenesis and tumor growth through a nonhemo- static mechanism. Cancer Res 2003, 63, 2997-3000.